Lori Firmani
Equibles does not estimate personal net worth.
Get an email with a short summary when Damora Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get DMRA alertsAbout Lori Firmani
Lori Firmani is recorded as CFO at Damora Therapeutics, Inc. (DMRA). The newest filing on record that lists Lori Firmani as CFO at Damora Therapeutics, Inc. (DMRA) is dated April 29, 2026. Damora Therapeutics, Inc. reported in an 8-K filed November 10, 2025 that Lori Firmani was appointed Chief Financial Officer, effective November 10, 2025. The proxy statement of Damora Therapeutics, Inc. reports total compensation of $563,211 for Lori Firmani in fiscal 2025, including a base salary of $311,249. Disclosed compensation is on record for 2 fiscal years. Damora Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Damora Therapeutics, Inc. includes Jennifer Jarrett (CEO and Board Member), Sherwin Sattarzadeh (CEO and COO), Peter Harwin (Chairman and Board Member) and 7 others.
“The Board appointed Ms. Firmani as Chief Financial Officer of the Company and approved an increase in Ms. Firmani's base salary from $300,000 to $375,000.”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 29, 2026
Company network
Leadership on record at Damora Therapeutics, Inc.
- Jennifer Jarrett CEO, Board Member
- Sherwin Sattarzadeh CEO, COO
- Peter Harwin Chairman, Board Member
- Garrett Winslow General Counsel
- Brian Burkavage Chief Accounting Officer
- Amy Wechsler Board Member
- Anne Prener Board Member
- Cameron Turtle Board Member
- Chris Cain Board Member
- Chris Cain, Ph.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Damora Therapeutics, Inc. (DMRA) | Chief Financial Officer | $311,249 | $563,211 |
| 2024 | Damora Therapeutics, Inc. (DMRA) | Chief Financial Officer | $261,188 | $561,892 |